Supplementary Table 1 from IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non–Small Cell Lung Cancer Cells
Year: 2023
Type: supplementary-materials
Abstract: PDF - 35KB, Combination Index for dasatinib and FAK inhibitor PF562271.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362481255